glp-1 resources A Registered Dietitian's Guide to Medications Oral GLP-1s rapidly expanding user

doi: 10.1016/j.biocel.2006.07.001 29 WinkDAHinesHBChengRYSwitzerCHFlores-SantanaWVitekMPet al

[ 1 , 3 ] Epithalamin was studied extensively through the 1980s and 1990s for its effects on aging, immune function, and melatonin production in animal models and some human trials

NAD IV therapy Miami providers offer is usually described as cellular wellness support

Potential benefits being investigated include: Cognitive performance : Some small-scale human studies have shown mixed results on cognitive tasks among participants receiving GLP-1 receptor agonists, with no consistent pattern of improvement established in randomised trials to date Cognitive decline : Observational data from diabetes cohorts suggest that patients prescribed GLP-1 agents may experience different rates of cognitive deterioration compared to those on other diabetes medications, though causality cannot be established Dementia risk : Population-based studies have indicated a possible association between GLP-1 receptor agonist use and dementia diagnoses, though these findings require confirmation in prospective trials Neuroimaging markers : Early research is examining potential effects on brain structure and function, but definitive evidence of preservation of brain volume has not been established Important limitations and considerations: Limited human trial data : Most evidence comes from animal models or observational studies